Therapy for chronic myelogenous leukemia with marrow transplantation

Keyphrases

• Chronic Myeloid Leukemia 100%
• Marrow Transplantation 100%
• Hematologic 30%
• Interferon-α (IFN-α) 20%
• Graft-versus-host Disease (GvHD) 10%
• T Cells 10%
• Cell Therapy 10%
• Transplantation 10%
• Hematopoietic Stem Cells 10%
• Hematopoietic Cells 10%
• Lethal Infection 10%
• Disease Course 10%
• Chronic Phase 10%
• Mismatched Related Donor 10%
• Antileukemic Activity 10%
• Positive Selection 10%
• BCR-ABL 10%
• Young Patients 10%
• HLA-matched Donor 10%
• Cell Transplantation 10%
• Pretransplant 10%
• Graft Failure 10%
• High Incidence 10%
• Buffy Coat 10%
• Unrelated Donor 10%
• Dormant 10%
• Increased Incidence 10%
• HLA Antigens 10%
• Ablative Therapy 10%
• Cytogenetic Remission 10%
• Class I HLA 10%
• Second Transplantation 10%
• Successful Treatment 10%
• Molecular Genetic Techniques 10%

Medicine and Dentistry

• Chronic Myelogenous Leukemia 100%
• Hematopoietic Cell 40%
• Interferon 40%
• Cell Therapy 20%
• Graft Failure 20%
• Disease Course 20%
• T Lymphocyte 20%
• Ablation Therapy 20%
• Bone Marrow Failure 20%
• HLA Antigen 20%
• Graft Versus Host Reaction 20%
• Diseases 20%